News

Tenaya Therapeutics could earn up to $1.1B for new heart disease research

Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.

Ligence Heart is a recently FDA cleared AI that fully automates analyses, measurements and reporting for transthoracic echo.

Cardiology now has more than 200 FDA-cleared AI algorithms

Cardiology is No. 2 behind radiology when it comes to FDA-cleared AI algorithms. Neurology, meanwhile, is a distant No. 3.

Philips has secured U.S. Food and Drug Administration (FDA) clearance for SmartHeart, the company’s new artificial intelligence (AI)-powered planning technology for cardiac MR (CMR) exams.

FDA clears AI-enabled cardiac MR planning technology from Philips

The new SmartHeart technology automates 14 cardiac views in less than 30 seconds. It was designed to increase productivity and bring more consistency to cardiology and radiology departments.

FDA warns public about reprocessed catheter recalls—devices should be destroyed

Back in February, several reprocessed EP and ultrasound catheters were recalled due to a risk of contamination. The FDA is now sharing additional information with the public.

Radiology experts develop practical framework for evaluating AI models before purchasing

Stanford and Rad Partners recently developed a structured, pre-deployment method for assessing radiology AI models, detailing their work in the American Journal of Roentgenology.

American College of Radiology criticizes administration’s push to make higher education more affordable

In January, the Department of Education released a proposed rule seeking to simplify federal student loan repayment, including "commonsense loan caps" and "streamlining repayment options."

Two drug suppliers plead guilty in $50M ‘straw purchase’ resale scheme

The two men, Frank Incognito, 46, and Stephen Corba, 50, conspired with doctors in a scheme involving the fraudulent purchase of critical cancer and macular degeneration drugs, which were then diverted and resold for profit. The U.S. Department of Justice said the unlawful pact lasted seven years.

CVS Health taps Google Cloud for new AI patient engagement platform

Dubbed Health100, the application is being launched as a subsidiary of CVS Health, utilizing Google’s cloud infrastructure data access and security. Powered by AI, Health100 is said to be a full assistant to help patients find providers, services and prescriptions, with the aim being to reduce out-of-pocket spending.

Society of Interventional Radiology offers new guidance for treating chronic pelvic pain

The new guidelines focus on pelvic venous disorders, which can cause a wide array of painful symptoms.

doctor patient elderly check up hospital

Heart patients unsure about GLP-1 drugs? A physician’s advice is often the best medicine

When patients fear that GLP-1 drugs are “too new” to be trusted, cardiologists can make a world of difference by closely listening and then explaining how they work.

Radiology societies fight Medicare Administrative Contractor’s proposed coverage restriction

National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR.

RadNet has allocated over $340M to acquisitions already in 2026. Leaders discuss why and what’s next

The Los Angeles-based imaging center operator recently reached a deal to acquire AI firm Gleamer for $270 million, on top of spending $74 million to add over a dozen imaging centers.

Around the web

Cardiovascular Business

Tenaya Therapeutics could earn up to $1.1B for new heart disease research